EUVIMEDObjevte EUVIMED
Open access

FTO ‐mediated m6A modification of protein disulfide‐isomerase activates VEGFA – VEGFR2 to suppress programmed cell death in osteosarcoma

Jiashi Wang, Yingying Hao, Ming He, Weizheng Zhou iD

The Journal of Pathology · 2026-09 · 270 (1) · 69-82

DOI: 10.1002/path.70083 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2026-06-05. Written by Jiashi Wang and 3 co-authors. Institution: Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, PR China. Major MEDLINE topics: Osteosarcoma, Bone Neoplasms, Apoptosis, Vascular Endothelial Growth Factor A. Cited 1 times so far (Crossref); 27 references. The full text is freely available in PubMed Central. Funded by: Natural Science Foundation of Liaoning Province, China, Joint Program of Science and Technology Plan of Liaoning Province (Natural Science Foundation General Project), 345 Talent Project of Shengjing Hospital.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Osteosarcoma (OS) is a primary bone malignancy, and its progression can be hindered by inducing programmed cell death (PCD). Protein disulfide‐isomerase (PDI) regulates cancer cell death; however, its functional role in OS remains unclear. P4HB expression was assessed in tumor tissues and cells from patients with OS using RT‐qPCR. The effects of P4HB on OS cell lines were evaluated. Western blotting was used to assess the impact of P4HB on various forms of PCD (apoptosis, ferroptosis, and pyroptosis). Bioinformatics analysis identified the upstream and downstream mechanisms of P4HB in OS progression. A xenograft tumorigenesis study was performed to elucidate the role and mechanism of P4HB in OS progression. Elevated P4HB expression was observed in OS tissue samples and cell lines. Downregulation of P4HB suppressed OS cell growth, migration, and invasiveness and induced PCD. Functional enrichment analysis and experimental validation revealed that PDI upregulated vascular endothelial growth factor A (VEGFA) vascular endothelial growth factor receptor 2 (VEGFR2) signaling. Methylation analysis showed that the m6A demethylase fat mass and obesity‐associated protein (FTO) decreased P4HB m6A levels and enhanced VEGFA–VEGFR2 signaling in OS cells. Moreover, FTO overexpression enhanced the proliferative, migratory, and invasive capabilities of OS cells and decreased PCD. Finally, FTO knockdown inhibited tumor growth and lung metastasis of OS by decreasing the activity of the PDI/VEGFA–VEGFR2 signaling axis. Mechanistically, FTO ‐mediated m6A modification of P4HB regulates PCD in OS through activation of this axis. © 2026 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

OsteosarcomaBone NeoplasmsApoptosisVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Alpha-Ketoglutarate-Dependent Dioxygenase FTOProtein Disulfide-IsomerasesHumansAnimalsSignal TransductionCell Line, TumorFemaleGene Expression Regulation, NeoplasticMiceMice, NudeCell ProliferationMaleCell Movement

Author keywords

fat mass and obesity‐associated proteinm6A modificationosteosarcomaprogrammed cell deathprotein disulfide‐isomerasevascular endothelial growth factor A ‐ vascular endothelial growth factor recep…

Substances

Vascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Alpha-Ketoglutarate-Dependent Dioxygenase FTOProtein Disulfide-IsomerasesVEGFA protein, human

Authors and institutions

  • Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, PR China.
  • Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, PR China.
  • Department of Pediatric Orthopaedics, Shengjing Hospital of China Medical University, Shenyang, PR China.

ORCID profiles: Weizheng Zhou

Funding

  • Natural Science Foundation of Liaoning Province, China
  • Joint Program of Science and Technology Plan of Liaoning Province (Natural Science Foundation General Project)
  • 345 Talent Project of Shengjing Hospital
  • Natural Science Foundation of Liaoning Province

Cite

APA

Wang, J., Hao, Y., He, M., & Zhou, W. (2026). FTO ‐mediated m6A modification of protein disulfide‐isomerase activates VEGFA – VEGFR2 to suppress programmed cell death in osteosarcoma. The Journal of Pathology, 270(1), 69-82. https://doi.org/10.1002/path.70083

Vancouver

Wang J, Hao Y, He M, Zhou W. FTO ‐mediated m6A modification of protein disulfide‐isomerase activates VEGFA – VEGFR2 to suppress programmed cell death in osteosarcoma. The Journal of Pathology. 2026;270(1):69-82. doi:10.1002/path.70083

BibTeX
@article{Wang2026,
  author = {Wang, Jiashi and Hao, Yingying and He, Ming and Zhou, Weizheng},
  title = {FTO ‐mediated m6A modification of protein disulfide‐isomerase activates VEGFA – VEGFR2 to suppress programmed cell death in osteosarcoma},
  journal = {The Journal of Pathology},
  year = {2026},
  volume = {270},
  number = {1},
  pages = {69--82},
  doi = {10.1002/path.70083}
}
Start for free →